Hydralazine hydrochloride and Simvastatin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydralazine hydrochloride (hydralazine hydrochloride) and Simvastatin (simvastatin). Common drug interactions include myocardial infarction among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Hydralazine hydrochloride and Simvastatin. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Hydralazine hydrochloride?

Hydralazine hydrochloride has active ingredients of hydralazine hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 1,238 Hydralazine hydrochloride users. Check the latest studies of Hydralazine hydrochloride.

What is Simvastatin?

Simvastatin has active ingredients of simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 256,970 Simvastatin users. Check the latest studies of Simvastatin.



On Aug, 02, 2026

37 people who take Hydralazine hydrochloride and Simvastatin together, and have interactions are studied.

Hydralazine hydrochloride and Simvastatin drug interactions.

What are the common drug interactions of Hydralazine Hydrochloride and Simvastatin, by gender? *:

female:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Pain in extremity
  3. Pneumonia
  4. Pruritus (severe itching of the skin)
  5. Pulmonary alveolar haemorrhage (acute bleeding)
  6. Renal failure (kidney dysfunction)
  7. Sneezing
  8. Cellulitis (infection under the skin)
  9. Contusion (a type of hematoma of tissue in which capillaries)
  10. Dark circles under eyes

male:

  1. Pain
  2. Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
  3. Dizziness
  4. Fall
  5. Headache (pain in head)
  6. Loss of consciousness
  7. Memory impairment
  8. Pneumonia
  9. Pyrexia (fever)
  10. Skin haemorrhage (bleeding into skin)

What are the common drug interactions of Hydralazine Hydrochloride and Simvastatin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abasia (inability to walk)
  2. Activated partial thromboplastin time prolonged
  3. Alanine aminotransferase increased
  4. Aspartate aminotransferase increased
  5. Ataxia (loss of full control of bodily movements)
  6. Atrioventricular block first degree (heart block first degree)
  7. Balance disorder
  8. Blood creatinine increased
  9. Blood pressure systolic increased
  10. Blood urea increased

30-39:

n/a

40-49:

  1. Depression
  2. Pain
  3. Electrocardiogram st segment elevation
  4. Foot fracture

50-59:

  1. Chest pain
  2. Chronic kidney disease
  3. Coma (state of unconsciousness lasting more than six hours)
  4. Contusion (a type of hematoma of tissue in which capillaries)
  5. Cystitis (inflammation of the wall of the bladder)
  6. Diarrhoea
  7. Dizziness
  8. Dysphonia (speech disorder attributable to a disorder of phonation)
  9. Fall
  10. Fatigue (feeling of tiredness)

60+:

  1. Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
  2. Anaemia (lack of blood)
  3. Pulmonary alveolar haemorrhage (acute bleeding)
  4. Pyrexia (fever)
  5. Skin haemorrhage (bleeding into skin)
  6. Tremor (trembling or shaking movements in one or more parts of your body)
  7. Cellulitis (infection under the skin)
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Dark circles under eyes
  10. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

What are the existing conditions these people have? *

  1. Pain: 9 people, 24.32%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 16.22%
  3. Pneumonia: 5 people, 13.51%
  4. Joint Pain: 5 people, 13.51%
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 10.81%
  6. Hypersensitivity: 4 people, 10.81%
  7. Muscle Spasms (muscle contraction): 4 people, 10.81%
  8. Asthma: 3 people, 8.11%
  9. Blood Oestrogen Decreased: 3 people, 8.11%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 8.11%

* Approximation only. Some reports may have incomplete information.

Do you take Hydralazine hydrochloride and Simvastatin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Hydralazine hydrochloride and Simvastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hydralazine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Simvastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydralazine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Simvastatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydralazine hydrochloride and simvastatin (the active ingredients of Hydralazine hydrochloride and Simvastatin, respectively), and Hydralazine hydrochloride and Simvastatin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: